In this free webinar, learn how in vivo PK/PD and efficacy models drive progress in oncology, immunology and fibrosis, with real-world case studies showcasing...
Industry leaders from NASA, TEL, and other organizations will showcase how modeling and simulation benefits their work at the COMSOL Conference 2025 Boston
NEWARK, N.J., Aug. 5, 2025 /PRNewswire/ -- New Jersey Innovation Institute (NJII), a subsidiary of the New Jersey Institute of Technology (NJIT), is pleased...
SAN BERNARDINO, Calif., Aug. 4, 2025 /PRNewswire/ -- Locksley Resources (ASX: LKY; OTCQB: LKYRF – today announced the company submitted an expanded Plan...
Certara today announced that the European Medicines Agency has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
SINGAPORE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ostium, a decentralized trading platform, has announced the launch of a new leveraged trading instrument: 0DTE perpetuals for equities. The instrument combines intraday expiry with perpetual structure, offering day traders up to 100x leverage on individual stocks during market hours — a structural innovation aimed at addressing the limitations of traditional options and CFDs.
LOS ANGELES, Aug. 1, 2025 /PRNewswire/ -- Insurance Commissioner Ricardo Lara is breaking his promise to Californians by guaranteeing rate hikes without guaranteeing more coverage,...
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.
NEWARK, Del., Aug. 1, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce Project Call 9.1 for...
Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor
SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- Blacksmith Medicines,...